Advantages Over Conventional Nanomedicine
Unlike traditional nanoparticle-based therapies, DNA nanobots offer unmatched programmability and precision. Their structure can be tailored at the molecular level, allowing for highly specific targeting and controlled drug release. Additionally, DNA’s natural biocompatibility reduces the risk of immune reactions or toxicity. This combination of adaptability and safety makes DNA nanobots a significant upgrade over conventional nanomedicine, promising more effective and patient-friendly cancer treatments.